Clinical Trial Update: Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation [Phase 2]

View source ↗

Summary

A Phase 2 trial completed evaluating sentinel lymph node biopsy after peritumoral injection with blue dye confirmation in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED